A Leader in Regenerative Medicine
In addition to ACell’s eleven 510(k) clearances, we are currently conducting and planning studies and registries to broaden the use of ACell’s device solutions and expand reimbursement for devices currently cleared by the FDA, all with the goal of benefitting a broader range of patients’ needs.
|Esophageal Reinforcement||Post-market study using Gentrix™ Surgical Matrix for reinforcement of esophageal repair for patients undergoing esophagectomy|
|Pelvic Floor Registry||Post-market study comparing ACell Pelvic Floor Matrix to transvaginal native tissue repair for the treatment of pelvic organ prolapse|
|Hiatal Hernia||Post-market study using Gentrix Surgical Matrix devices for hiatal hernia repair|